El tratamiento farmacológico hipolipemiante con estatinas debería ser el más indicado en los individuos con Institut Català de Farmacologia. REVISIONES. Interacciones medicamentosas de agentes hipolipemiantes: aproximación para establecer y valorar su relevancia clínica. Revisión estructurada. As estatinas são agentes hipolipemiantes que exercem os seus efeitos através da inibição da HMG-CoA redutase, enzima fundamental na síntese do colesterol .

Author: Daik Nikobar
Country: Djibouti
Language: English (Spanish)
Genre: Life
Published (Last): 13 March 2014
Pages: 40
PDF File Size: 4.7 Mb
ePub File Size: 5.21 Mb
ISBN: 859-1-55029-160-4
Downloads: 40922
Price: Free* [*Free Regsitration Required]
Uploader: Mazulabar

Se obtuvieron publicaciones, de las cuales se seleccionaron referencias, en las los que se identificaron interacciones. Drug Metabol Drug Hipolipemianted. Rhabdomyolysis associated with simvastatin-nefazodone therapy.

Influence of statin treatment on platelet inhibition by clopidogrel-a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.

Drug interaction caused by communication problems. Eur J Clin Pharmacol. Effect of the bile acid sequestrant colesevelam on the pharmacokinetics of pioglitazone, repaglinide, estrogen estradiol, norethindrone, levothyroxine, and glyburide. FDA adverse event reports on statin-associated rhabdomylolysis. Statins inhibit HIV-1 infection by down-regulating Rho activity. Polymorphisms in human MDR1 P-glycoprotein: Lack of effect of gemfibrozil on cyclosporine blood concentrations in kidney-transplanted patients.

Effect of linagliptin BI on the steady-state pharmacokinetics of simvastatin. Coadministration of dabigatran etexilate and atorvastatin: A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane.


Agentes Hipolipemiantes by Patricia Maruo on Prezi

Ros E, Laguna JC. Pharmacokinetic and pharmacodynamic assessments of HMG-CoA reductase inhibitors when coadministered with everolimus.

Evaluation of a pharmacokinetic interaction between valsartan and simvastatin in healthy subjects. HMG-CoA reductase inhibitors in osteoporosis: Endocrinol Metab Clin North Am.

Fármacos Hipolipemiantes

Cardiovascular risk and human immunodeficiency virus infection: Pharmacokinetic and pharmacodynamic alterations of 3-hydroxymethylglutaryl coenzyme A HMG-CoA reductase inhibitors: Shitara Y, Sugiyama Y. John’s wort product Movina and atorvastatin in patients with hypercholesterolemia. Fibrates in the treatment of dyslipidemias-time for a reassessment. Multiple organ toxicity from addition of erythromycin to long-term lovastatin therapy.

Hypolipidemic agents drug interactions: ,os coadministration increases plasma atorvastatin concentrations. Monsalve 1,4F. Acute rhabdomyolysis caused by combination therapy with atorvastatin and warfarin.

Effects of ezetimibe on cyclosporine pharmacokinetics in healthy subjects. Drug interaction between oral atorvastatin and verapamil in healthy subjects: Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers.

Pleiotropic effects of statins: Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A. Rhabdomyolysis in a patient receiving atorvastatin and fluconazole. Cerivastatin and reports of fatal rhabdomyolysis. Jardine A, Holdaas Llos. Potential interaction between troglitazone and atorvastatin.

Pharmacokinetics of statins

Rhabdomyolysis due to an uncommon interaction of ciprofloxacin with simvastatin. Pharmacokinetic interaction between isradipine and lovastatin in normal, female and male volunteers. Rhabdomyolysis with concurrent atorvastatin and diltiazem.


Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: Interacciones medicamentosas de etravirina. Am J Cardiovasc Drugs. To carry out a structures review of drug interactions of hypolipidemic drugs and to assess their clinical relevance.

Effect of clopidogrel on the steady-state pharmacokinetics of fluvastatin. El diltiazem puede causar un aumento en la Cmax en 3,6 veces y el ABC en 5 veces de la simvastatina y de 3,5 veces el ABC de lovastatina; efecto que no se evidencia en el caso de la pravastatina Am J Cardiol ;96 suppl 9A: Pleiotropic effects of statins.

Statin prevents tissue factor expression in human endothelial cells: Concomitant administration of simvastatin and danazol associated with fatal rhabdomyolysis. Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin. Acute renal failure with the combined use of rosuvastatin and fenofibrate.

A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine.

Previous post:
Next post: